HOKKAのデビューアルバム「Via Miseria IV」日本盤発売日Amazon🇯🇵のHR/HM 部門 ランキング:
Hot New Release #7
Best Seller #16
少なくともこのビジュアル(刀のマイクスタンド)と名前(北海道に似てる😁)日本のマーケットにあってるかも。
ヨエルのIGストーリーより。
저는 양극성 장애 진단을 받고 약을 먹은 후에 기쁨도 별로 느껴지지 않고, 슬픔도 별로 느껴지지 않아서 의사선생님께 말씀드렸더니, 보통의 일반인들이 그 정도 세기의 감정을 느낀다고 알려 주셨다.
그동안 영화 보다가 슬퍼서 대성통곡을 하고 영화 내용을 떠올리며 며칠을 힘들어하거나 기쁜 기분에 신나서 며칠동안 즐거웠던 모든 것이 양극성 장애의 증상인 것이었음...
What Eminem said about Michael Jackson.
“I have nothing against him. He’s the King of Pop nobody comes close to him. He’s better than me, better than everyone else. I just wish we had reconciled before he died.”
Breakthrough lab research reveals that cannabis compounds, including THC, can help clear toxic Alzheimer's-related proteins from brain cells.
In groundbreaking studies from the Salk Institute and Scripps Research Institute, scientists have demonstrated that tetrahydrocannabinol (THC) and other cannabinoids show strong potential to address key drivers of Alzheimer's disease. When tested on human neuronal cell cultures, these compounds activated the brain's endocannabinoid system to:
- Promote the removal of toxic amyloid-beta proteins — the sticky molecules that clump into plaques and spark chronic brain inflammation.
- Reduce the activity of enzymes (such as β-secretase and γ-secretase) that produce more amyloid-beta, thereby slowing plaque buildup.
- Protect neurons from inflammation-induced damage and oxidative stress.
The findings suggest that cannabinoids may offer neuroprotective effects by enhancing the brain's natural cleanup mechanisms and dampening harmful inflammatory responses — two central processes in Alzheimer's progression.
Importantly, the results come from in vitro (cell-based) experiments and animal models; no large-scale human clinical trials have yet confirmed these effects in people living with Alzheimer's or other dementias. Experts stress that while the work is promising and opens exciting avenues for future drug development, cannabis is not currently proven to prevent, treat, cure, or reverse Alzheimer's disease.
This early-stage research provides a compelling scientific foundation for exploring cannabinoid-based therapies — potentially combining THC and CBD — as part of a broader strategy to combat neurodegenerative decline.
[Salk Institute for Biological Studies. Cannabinoids remove plaque-forming Alzheimer's proteins from nerve cells. Nature: Aging and Mechanisms of Disease]